Literature DB >> 16420252

nef gene sequence variation among HIV-1-infected African children.

R Chakraborty1, M Reinis, T Rostron, S Philpott, T Dong, A D'Agostino, R Musoke, E Silva, M Stumpf, B Weiser, H Burger, S L Rowland-Jones.   

Abstract

BACKGROUND: There are few data on African children infected with nonclade B HIV-1 in endemic settings, which limits generalizations about pathogenesis and progression. Genotypic and phenotypic variations in host immunogenetics and HIV-1 negative factor (nef) accessory protein may influence disease progression and have frequently been characterized in subjects infected with clade B HIV-1.
METHODS: In this descriptive study, we report nef gene sequence variation and host genetic polymorphisms in 32 Kenyan children, including 12 slow progressors.
RESULTS: Phylogenetic analysis identified HIV-1 clades A, C and D and a recombinant A/D subtype. Grossly defective nef genes or significant changes from relevant clade reference sequences were not identified in children with delayed disease progression.
CONCLUSIONS: nef sequence variations may not be common in perinatally infected African children. Further studies are warranted in HIV-1-infected subjects in settings where infection is endemic.

Entities:  

Mesh:

Year:  2006        PMID: 16420252     DOI: 10.1111/j.1468-1293.2006.00341.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  2 in total

1.  Meta-analysis to test the association of HIV-1 nef amino acid differences and deletions with disease progression.

Authors:  Ravindra Pushker; Jean-Marc Jacqué; Denis C Shields
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

2.  Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children.

Authors:  Matilda Chelimo Saina; Xiuqiong Bi; Raphael Lihana; Raphael Lwembe; Azumi Ishizaki; Annie Panikulam; Tresa Palakudy; Rachel Musoke; Mary Owens; Elijah Maritim Songok; Hiroshi Ichimura
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.